Will social distancing resume?
By Kim, Jin-Gu | translator Choi HeeYoung
22.07.13 06:00:55
°¡³ª´Ù¶ó
0
As COVID-19 spreads again, the pharmaceutical industry is concerned
Review internal guidelines such as refraining from offline events and recommending distributed vacations
As the spread of the coronavirus is intensifying again, concerns in the pharmaceutical bio industry are also growing.
Front-line companies seem to be paying keen attention to whether to resume social distancing measures, while asking executives and employees to strengthen personal quarantine rules ahead of the full-fledged summer vacation season.
¡ß Please strengthen personal quarantine rules. & refrain from face-to-face meetings
According to the Korea Centers for Disease Control and Prevention on the 13th, as of midnight on the 11th, there were 37,360 new confirmed patients in Korea. It is the first time in more than two months that the number of new confirmed patients
Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)